Metropolis Healthcare Ltd Analyst Rating
based on 17 analysts
58.82%
Buy
5.88%
Hold
35.29%
Sell
Based on 17 analysts offering long term price targets for Metropolis Healthcare Ltd. An average target of ₹2187.29
Source: S&P Global Market Intelligence
Metropolis Healthcare Ltd Share analysis
Metropolis Healthcare Ltd price forecast by 17 analysts
Upside of2.86%
High
₹2650
Target
₹2187.29
Low
₹1729
Metropolis Healthcare Ltd target price ₹2187.29, a slight upside of 2.86% compared to current price of ₹2058.05. According to 17 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Metropolis Healthcare Ltd revenue growth forecast
Expected growth rate Q1, FY2026:27.18%
Forecast
Actual
Including amortisation and stock based compensations
Metropolis Healthcare Ltd EPS growth forecast
EPS estimate Q1, FY2026:74.91%
Forecast
Actual
Source: S&P Global Market Intelligence
Metropolis Healthcare Ltd Performance
Day's Low
Day's High
₹2,052.15Day's Price Range₹2,131.1552 Week's Low
52 Week's High
₹1,45052-Week Price Range₹2,318.3
| Returns % | |
| 1 Month Return | + 5.49 % |
| 3 Month Return | -2.26 % |
| 1 Year Return | + 24.39 % |
| Market Stats | |
| Previous Close | ₹2,126.40 |
| Open | ₹2,118.65 |
| Volume | 71.20K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹10,928.15Cr |
Metropolis Healthcare Ltd Key Statistics
| P/E Ratio | 73.58 |
| PEG Ratio | 25.73 |
| Market Cap | ₹10,928.15 Cr |
| P/B Ratio | 8.58 |
| EPS | 25.08 |
| Dividend Yield | 0.23 |
| Sector | Healthcare |
| ROE | 11.78 |
Metropolis Healthcare Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| HOLD | ₹10,928.15 Cr | 11.77% | 0.58 | ₹128 Cr | ₹1,207 Cr | |
| BUY | ₹10,991.10 Cr | 14.19% | 0.64 | ₹119 Cr | ₹547 Cr | |
| BUY | ₹5,268.71 Cr | 15.57% | 0.54 | ₹69 Cr | ₹571 Cr | |
| HOLD | ₹25,400.23 Cr | 21.5% | 0.55 | ₹362 Cr | ₹2,226 Cr | |
| HOLD | ₹30,567.64 Cr | 136.37% | 0.67 | ₹168 Cr | ₹5,040 Cr |
Metropolis Healthcare Ltd Mutual Fund Holdings
About Metropolis Healthcare Ltd
The company offers a wide range of products and services, including clinical laboratory services, imaging services, pathology services, and wellness services. Metropolis Healthcare Ltd also provides a range of specialty services, such as genetic testing, molecular diagnostics, and bio-banking. It is one of the leading providers of healthcare services in India.
The company's top products include clinical laboratory tests, imaging services, pathology services, and wellness services. It also offers a range of popular services under the brands: Metropolis, Metropolis Health Plus, Metropolis Health Care, and Metropolis Health Care Plus.
Share Price: ₹2058.05 per share as on 20 Dec, 2024 04:01 PM
Market Capitalisation: ₹10,928.15Cr as of today
Revenue: ₹349.79Cr as on September 2024 (Q3 24)
Net Profit: ₹46.70Cr as on September 2024 (Q3 24)
Listing date: 15 Apr, 2019
Chairperson Name: Sushil Kanubhai Shah
| Organisation | Metropolis Healthcare Ltd |
| Headquarters | |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Key events for Metropolis Healthcare Ltd
Metropolis Healthcare Sees Growth in Tier-2 and Tier-3 Revenues - 18 Dec, 2024
As of H1FY25, tier-2 and tier-3 towns contribute 34% of Metropolis Healthcare's revenues, with tier-3 city revenue growing by 23% year-on-year.Metropolis Healthcare Targets Growth with Core Diagnostics Acquisition - 13 Dec, 2024
ICICI Securities maintains an 'Add' rating on Metropolis Healthcare, raising the target price to Rs 2,335. The company plans to acquire Core Diagnostics to enhance its oncology market presence and diversify geographically. The acquisition is expected to accelerate growth in a fast-growing sector.Metropolis Healthcare Acquires Core Diagnostics for Growth - 10 Dec, 2024
Metropolis Healthcare announced the acquisition of Core Diagnostics for Rs 246.8 crore, aiming to enhance its cancer testing capabilities and expand its market presence in Northern and Eastern India. The deal involves 55% cash and 45% equity swap, expected to complete within 60 days, subject to shareholder approval.Metropolis Healthcare Acquires Core Diagnostics for Growth - 09 Dec, 2024
Metropolis Healthcare has approved the acquisition of Core Diagnostics for ₹246.8 crore, aiming to enhance its cancer testing capabilities and expand its market presence in northern and eastern India. The acquisition will be financed through a mix of cash and stock, with Core becoming a wholly owned subsidiary post-completion.Metropolis Healthcare Sees Surge in Trading Volume - 06 Dec, 2024
Metropolis Healthcare Ltd experienced a significant trading volume of 6.87 lakh shares, a 7.46 times increase over the two-week average. The stock rose by 1.32% to Rs. 2,127.90.
Insights on Metropolis Healthcare Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 315.81 Cr → 352.92 Cr (in ₹), with an average increase of 10.5% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 4 quarters, 27.16 Cr → 46.52 Cr (in ₹), with an average increase of 16.0% per quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 18.25% to 18.56% in Sep 2024 quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 23.67% to 24.33% in Sep 2024 quarter
NO EFFECTAgainst Peers
In the last 1 year, Max Healthcare Institute Ltd has given 79.7% return, outperforming this stock by 49.6%
- NO EFFECT
Against Peers
In the last 3 years, Max Healthcare Institute Ltd has given 207.8% return, outperforming this stock by 239.6%
NEGATIVE IMPACTPrice Dip
In the last 3 years, METROPOLIS stock has moved down by -31.8%
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 49.62% to 49.43% in Sep 2024 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 4.70% to 3.99% in Sep 2024 quarter
Metropolis Healthcare Ltd Financials
Index Inclusions
Metropolis Healthcare Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 49.43% | ||
| Foreign Institutions | 18.56% | 1.68 | |
| Mutual Funds | 24.33% | 2.76 | |
| Retail Investors | 3.99% | ||
| Others | 3.69% |
Metropolis Healthcare Ltd Key Indicators
Metropolis Healthcare Ltd Valuation
Metropolis Healthcare Ltd in the last 5 years
Lowest (33.38x)
June 22, 2022
Today (73.58x)
December 19, 2024
Industry (105.00x)
December 19, 2024
Highest (98.05x)
September 15, 2020
Metropolis Healthcare Ltd Earnings and Dividends
Metropolis Healthcare Ltd Earnings Results
Metropolis Healthcare Ltd’s net profit jumped 31.23% since last year same period to ₹46.52Cr in the Q2 2024-2025. On a quarterly growth basis, Metropolis Healthcare Ltd has generated 22.58% jump in its net profits since last 3-months.
Read More about Earnings ResultsMetropolis Healthcare Ltd Dividends November,2023
In the quarter ending September 2023, Metropolis Healthcare Ltd has declared dividend of ₹4 - translating a dividend yield of 0.58%.
Read More about Dividends
Metropolis Healthcare Ltd Technicals Summary
Bearish
Neutral
Bullish
Metropolis Healthcare Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Metropolis Healthcare Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Metropolis Healthcare Ltd shares.
Metropolis Healthcare Ltd (METROPOLIS) share price today is ₹2058.05
Metropolis Healthcare Ltd is listed on NSE
Metropolis Healthcare Ltd is listed on BSE
- Today’s highest price of Metropolis Healthcare Ltd is ₹2131.15.
- Today’s lowest price of Metropolis Healthcare Ltd is ₹2052.15.
PE Ratio of Metropolis Healthcare Ltd is 73.58
PE ratio = Metropolis Healthcare Ltd Market price per share / Metropolis Healthcare Ltd Earnings per share
Today’s traded volume of Metropolis Healthcare Ltd(METROPOLIS) is 71.20K.
Today’s market capitalisation of Metropolis Healthcare Ltd(METROPOLIS) is ₹10928.15Cr.
| Metropolis Healthcare Ltd(METROPOLIS | Price |
|---|---|
52 Week High | ₹2318.3 |
52 Week Low | ₹1450 |
Metropolis Healthcare Ltd(METROPOLIS) share price is ₹2058.05. It is down -11.23% from its 52 Week High price of ₹2318.3
Metropolis Healthcare Ltd(METROPOLIS) share price is ₹2058.05. It is up 41.93% from its 52 Week Low price of ₹1450
| Metropolis Healthcare Ltd(METROPOLIS | Returns |
|---|---|
1 Day Returns | -68.35% |
1 Month Returns | 5.49% |
3 Month Returns | -2.26% |
1 Year Returns | 24.39% |